Friday, 19 October 2018

Lupin gets EDQM nod for its Mandideep facility

30 July 2018 | News

Over the past few months, Lupin has continued to drive multiple initiatives to further strengthen manufacturing standards and best practices to be amongst the best, he added.

Image Credit: Wikipedia

Image Credit: Wikipedia

Drug firm Lupin has said that it has received attestation from European Directorate for the Quality of Medicines (EDQM) for its Mandideep facility in Madhya Pradesh. The unit was inspected by EDQM in March this year.

"The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for Quality Management Systems based on cGMP as laid under European Union rules governing medicinal products," according to the company.

Lupin MD Nilesh Gupta said: "We are happy to receive the EDQM attestation for our Mandideep facility."

Over the past few months, Lupin has continued to drive multiple initiatives to further strengthen manufacturing standards and best practices to be amongst the best, he added.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls